An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging
Neurological diseases are disorders that affect the central nervous system and can impair the brain, spinal cord, peripheral nerve or neuromuscular function. Most of diseases are directly related to ageing, being Alzheimer’s Disease (AD) and stroke especially relevant due to its incidence and economic burden. More than 7.5 million European citizens aging between 30 and 99 years suffer from different types of dementia. NEUROATLANTIC aims at bringing together the remarkable scientific and technological capacities within the Atlantic Area in the field of the neurological diseases (eg Alzheimer’s Disease, Stroke, etc). This project will act on the clinical, preclinical and capitalization aspects accelerating the uptake of new innovations that will revolutionaze the way in which neurological diseases are handled within the area. NEUROATLANTIC will focus on setting up a transnational platform to develop novel theragnostics agents to treat and early diagnosis of these devastating and prevalent diseases.